Description: Anoro Ellipta 62.5 by 25 mcg Inhalation Powder is used for the long-term, once-daily maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. This inhaler combines two bronchodilators to help relax and open the airways, making breathing easier.
Ingredients:
-
Active Ingredients:
- 62.5 mcg of Umeclidinium (an anticholinergic)
- 25 mcg of Vilanterol (a long-acting beta2-adrenergic agonist)
-
Other Ingredients:
- Lactose monohydrate (contains milk proteins)
Usage Instructions:
-
Dosage: One inhalation once daily.
-
Frequency: Once daily at the same time each day.
-
Special Considerations: Rinse your mouth with water without swallowing after inhalation to reduce the risk of throat irritation and infection. Ensure proper inhaler technique for effective medication delivery.
Benefits:
- Provides 24-hour relief from symptoms of COPD.
- Improves lung function and reduces the frequency of COPD exacerbations.
- Enhances overall quality of life by making breathing easier and reducing symptoms like shortness of breath.
Precautions:
-
Contraindications: Do not use if you are allergic to umeclidinium, vilanterol, or any components of the inhaler. Not intended for use in treating asthma or acute bronchospasm.
-
Side Effects: Possible side effects include sore throat, sinusitis, cough, and headache. Serious side effects may include cardiovascular effects, paradoxical bronchospasm, and allergic reactions.
-
Warnings: Use with caution in patients with cardiovascular disorders, seizures, thyroid disorders, or diabetes. Inform your healthcare provider of any other medications or supplements you are taking.
Storage Instructions:
- Store at room temperature (15°C to 25°C or 59°F to 77°F).
- Keep in a dry place away from direct sunlight and moisture.
- Keep out of reach of children.
- Discard the inhaler 6 weeks after opening or when the dose counter reads zero.
Manufacturer: GlaxoSmithKline Pharmaceuticals
